Moors & Cabot, Inc. Eli Lilly & CO Transaction History

Moors & Cabot, Inc.

$1.85 Billion
Q2 2024

A detailed history of Moors & Cabot, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Moors & Cabot, Inc. holds 20,882 shares of LLY stock, worth $19 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

20,882

Previous 19,653 6.25%

Holding current value

$19 Million

Previous $15.3 Million 23.66%

% of portfolio

1.02%

Previous 0.84%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $890,865 - $1.12 Million	1,229 Added 6.25%	20,882 $18.9 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $394,405 - $527,658	-666 Reduced 3.28%	19,653 $15.3 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $44,641 - $52,626	-85 Reduced 0.42%	20,319 $11.8 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $639,443 - $881,570	-1,471 Reduced 6.72%	20,404 $11 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $84,177 - $112,555	-240 Reduced 1.09%	21,875 $10.3 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $1.41 Million - $1.66 Million	4,541 Added 25.84%	22,115 $7.59 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $396,471 - $461,968	-1,233 Reduced 6.56%	17,574 $6.43 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $857,895 - $999,619	-2,668 Reduced 12.42%	18,807 $6.88 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $482,076 - $549,376	-1,626 Reduced 7.04%	21,475 $6.94 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $47,105 - $55,308	169 Added 0.74%	23,101 $7.49 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $216,618 - $269,202	-923 Reduced 3.87%	22,932 $6.57 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $743,354 - $922,506	3,306 Added 16.09%	23,855 $6.59 Million
Q3 2021 Dec 08, 2021	BUY	$221.6 - $272.71 $4.55 Million - $5.6 Million	20,549 New	20,549 $4.75 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $4.04 Million - $4.97 Million	-18,213 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $31,235 - $40,402	-173 Reduced 0.94%	18,213 $4.18 Million
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $74,765 - $96,787	455 Added 2.54%	18,386 $3.43 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $344,414 - $455,743	2,640 Added 17.27%	17,931 $3.03 Million
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $168,591 - $195,006	-1,153 Reduced 7.01%	15,291 $2.26 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $271,339 - $326,554	-1,989 Reduced 10.79%	16,444 $2.7 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $2,261 - $2,799	-19 Reduced 0.1%	18,433 $2.56 Million
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $84,146 - $104,222	-787 Reduced 4.09%	18,452 $2.42 Million
Q3 2019 Oct 22, 2019	BUY	$106.79 - $116.16 $112,556 - $122,432	1,054 Added 5.8%	19,239 $2.15 Million
Q2 2019 Jul 18, 2019	BUY	$110.79 - $129.32 $202,524 - $236,396	1,828 Added 11.18%	18,185 $2.01 Million
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $1.82 Million - $2.14 Million	-16,357 Reduced 50.0%	16,357 $2.13 Million
Q1 2019 May 01, 2019	BUY	$111.31 - $131.02 $1.8 Million - $2.12 Million	16,208 Added 98.19%	32,714 $4.25 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $1.43 Million - $1.6 Million	-13,460 Reduced 44.92%	16,506 $1.91 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $65,511 - $81,877	-763 Reduced 2.48%	29,966 $3.21 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $12,339 - $14,161	163 Added 0.53%	30,729 $2.63 Million
Q1 2018 May 18, 2018	BUY	$74.21 - $87.6 $42,522 - $50,194	573 Added 1.91%	30,566 $2.37 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $55,145 - $59,149	-673 Reduced 2.19%	29,993 $2.53 Million
Q3 2017 Nov 16, 2017	BUY	$77.07 - $85.54 $32,369 - $35,926	420 Added 1.39%	30,666 $2.62 Million
Q2 2017 Aug 15, 2017	BUY	N/A	30,246	30,246 $2.49 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account